Unknown

Dataset Information

0

Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials.


ABSTRACT: The use of external beam radiation therapy (EBRT) in the treatment of hepatocellular carcinoma (HCC), which was rarely performed due to liver toxicity with a previous technique, has increased. Palliation of portal vein thrombosis, supplementation for insufficient transarterial chemoembolization, and provision of new curative opportunities using stereotactic body radiotherapy are the potential indications for use of EBRT. The mechanism of EBRT treatment, with its radiobiological and physical perspectives, differs from those of conventional medical treatment or surgery. Therefore, understanding the effects of EBRT may be unfamiliar to physicians other than radiation oncologists, especially in the field of HCC, where EBRT has recently begun to be applied. The first objective of this review was to concisely explain the indications for use of EBRT for HCC for all physicians treating HCC. Therefore, this review focuses on the therapeutic outcomes rather than the detailed biological and physical background. We also reviewed recent clinical trials that may extend the indications for use of EBRT. Finally, we reviewed the current clinical practice guidelines for the treatment of HCC and discuss the current recommendations and future perspectives.

SUBMITTER: Rim CH 

PROVIDER: S-EPMC5962257 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials.

Rim Chai Hong CH   Yoon Won Sup WS  

OncoTargets and therapy 20180516


The use of external beam radiation therapy (EBRT) in the treatment of hepatocellular carcinoma (HCC), which was rarely performed due to liver toxicity with a previous technique, has increased. Palliation of portal vein thrombosis, supplementation for insufficient transarterial chemoembolization, and provision of new curative opportunities using stereotactic body radiotherapy are the potential indications for use of EBRT. The mechanism of EBRT treatment, with its radiobiological and physical pers  ...[more]

Similar Datasets

| S-EPMC5749761 | biostudies-literature
| S-EPMC7991715 | biostudies-literature
2012-12-21 | GSE30174 | GEO
| S-EPMC8539441 | biostudies-literature
| S-EPMC3831064 | biostudies-literature
2012-12-21 | E-GEOD-30174 | biostudies-arrayexpress
| S-EPMC5691027 | biostudies-literature
| S-EPMC5237353 | biostudies-literature
| S-EPMC3596128 | biostudies-other